https://www.pharmadoc.it/wp-content/uploads/2020/05/ricetta-prescrizione-37837146_I-copia.jpg
1280
1920
rossana
https://www.pharmadoc.it/wp-content/uploads/2020/12/pharmadoc-logo.png
rossana2020-05-19 11:10:392022-01-21 09:50:25Nota 13 AIFA rivede le sue posizioni rispetto alle combinazioni in dose fissa di statine ed Ezetimibe
https://www.pharmadoc.it/wp-content/uploads/2020/05/Magrini.png
998
1594
rossana
https://www.pharmadoc.it/wp-content/uploads/2020/12/pharmadoc-logo.png
rossana2020-05-11 19:08:172020-05-12 14:29:07Cambiano le regole per CTS e CPR
https://www.pharmadoc.it/wp-content/uploads/2020/04/144440425_l-copia.jpg
679
1920
rossana
https://www.pharmadoc.it/wp-content/uploads/2020/12/pharmadoc-logo.png
rossana2020-04-23 18:54:012022-12-09 15:59:22Acquisti urgenti di beni sanitari all’epoca del Coronavirus
https://www.pharmadoc.it/wp-content/uploads/2020/04/Payback-copia.jpg
1072
1500
rossana
https://www.pharmadoc.it/wp-content/uploads/2020/12/pharmadoc-logo.png
rossana2020-04-10 17:49:252020-04-10 17:49:25AIFA e Aziende farmaceutiche a lavoro, in remoto, per la verifica in contraddittorio degli oneri dovuti a titolo di payback per l’anno 2018
https://www.pharmadoc.it/wp-content/uploads/2020/03/93466683_xl-penna-adrenalina.jpg
1357
1920
rossana
https://www.pharmadoc.it/wp-content/uploads/2020/12/pharmadoc-logo.png
rossana2020-03-10 16:03:182020-03-10 16:20:35Sistemi di erogazione di un farmaco e lotti di gara. Siringa preriempita e penna preriempita “per me pari sono”, secondo il CDS
https://www.pharmadoc.it/wp-content/uploads/2020/02/payback.jpg
1005
1920
rossana
https://www.pharmadoc.it/wp-content/uploads/2020/12/pharmadoc-logo.png
rossana2020-02-14 21:38:312020-02-14 21:51:55Nuovi ricorsi avverso il payback
https://www.pharmadoc.it/wp-content/uploads/2020/01/emoderivati-copia.jpg
1530
1920
rossana
https://www.pharmadoc.it/wp-content/uploads/2020/12/pharmadoc-logo.png
rossana2020-01-29 11:56:182020-01-29 14:06:41Equivalenza terapeutica col V livello ATC per i Fattori VIII – il CDS per il lotto semplice competitivo
https://www.pharmadoc.it/wp-content/uploads/2019/10/comparison-drugs.jpg
1280
1920
rossana
https://www.pharmadoc.it/wp-content/uploads/2020/12/pharmadoc-logo.png
rossana2019-10-29 15:39:562019-10-29 16:57:43Sostituibilità automatica tra biosimilari – AIFA spinge per la riforma normativa
https://www.pharmadoc.it/wp-content/uploads/2019/10/Patient-safety-1.jpg
1183
1743
rossana
https://www.pharmadoc.it/wp-content/uploads/2020/12/pharmadoc-logo.png
rossana2019-10-15 12:27:152019-10-29 16:58:18Il rapporto rischio/beneficio – probatio diabolica per le aziende farmaceutiche? Il caso della sospensione dell’AIC per i prodotti a base di gadolinio.
https://www.pharmadoc.it/wp-content/uploads/2019/09/Copia-di-Growth_custom.jpg
1261
1920
rossana
https://www.pharmadoc.it/wp-content/uploads/2020/12/pharmadoc-logo.png
rossana2019-09-09 14:41:502019-09-09 14:41:50Farmaci equivalenti. Aumentano i volumi ma è a rischio la redditività.